Paige Minemyer

This discussion features Darren Incorvaia, a Staff writer at Fierce Biotech, who sheds light on how NIH funding cuts impact drug discovery. Fraser Kansteiner, a reporter/editor at Fierce Pharma, dives into the shifting dynamics within FDA vaccine policies. Angus Liu and Eric Sagonowsky provide insights on FDA leadership changes and their implications. The panel also evaluates the cautious optimism seen at the Jefferies Healthcare Conference, while Heather Landi and Paige Minemyer analyze the challenges providers face and the evolving role of AI in healthcare.

Join healthcare experts Dave Muoio, Associate Editor at Fierce Healthcare, and Paige Minemyer, Senior Writer at Fierce Healthcare, as they break down the looming regulatory changes set to impact the healthcare industry in late 2025. They discuss significant topics such as UnitedHealth Group's unexpected financial miss and CEO departure, elevated medical costs dragging down insurers, and the implications of Medicaid cuts. Their insights dive deep into how providers and payers are navigating these uncertain waters and adapting to evolving market demands.

In this insightful conversation, Paige Minemyer, Senior Writer at Fierce Healthcare, discusses the newly unveiled 2025 Fierce 15, a prestigious list of innovative healthcare companies. She highlights the evolution of the Fierce 15 project, spotlighting how the pandemic accelerated telehealth's rise to mainstream acceptance. Paige reveals the collaboration with the New York Stock Exchange and dives into the key criteria for selection, emphasizing the need for tangible impacts in healthcare innovation as AI and new technologies reshape the industry.